- MCA filings & documents
- P&L, balance sheet, cash flow & ratios
- Year-wise charts & analysis
- One credit = one full company report
- Use across any company, anytime
- Credits valid for 12 months
Key Metrics
Company Health Scores
Health scores for Elysium Pharmaceuticals covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.
- Blend of compliance (44), financial health (95), director (55) and company-foundation signals.
- Operating for 31+ years.
- Company status is Active as per MCA.
- Last balance sheet filed for Mar 2024 - slightly behind.
- Profitable in FY 2021.
- Positive net worth.
- 8 directors on the board.
- Director HIREN PRAKASH BAROT has DIN status "Disqualified by RoC u/s 164(2)".
About Elysium Pharmaceuticals
Elysium Pharmaceuticals is an MCA-registered Indian company: a Public Limited Indian Non-Government Company (CIN U24231GJ1995PLC024164). Business overview includes Pharma (Drug Formulation & Development), incorporated on January 11, 1995 (31+ years old), headquartered in Vadodara, Gujarat, India. The company is currently Active with Active Compliant compliance status.
- Location Plot No.1175, P.O. Dabhasa, Tal. Padra, Vadodara, Gujarat - 391440
- Website elysiumpharma.com
Financial Performance of Elysium Pharmaceuticals
| Metrics | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Profit/Loss | — | — | — | — | — |
| Cash & Bank Balance | — | — | — | — | — |
| Net Worth | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
Financial Ratios
Sign in to view ratio trends
| Ratio | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Net Profit Margin | — | — | — | — | — |
| Debt to EBITDA | — | — | — | — | — |
| Interest Coverage Ratio | — | — | — | — | — |
| Debt to Equity | — | — | — | — | — |
| Return on Equity | — | — | — | — | — |
| Current Ratio | — | — | — | — | — |
| Quick Ratio | — | — | — | — | — |
| EBITDA Margin | — | — | — | — | — |
| Return on Capital Employed | — | — | — | — | — |
| Earning Per Share | — | — | — | — | — |
EPFO Establishments (1)
Current Directors of Elysium Pharmaceuticals (8)
Charges of Elysium Pharmaceuticals
| Lender | Amount | Status |
|---|---|---|
|
Others
Creation Date: 15 Mar 2022 |
2.29 cr | Closed |
|
Others
Creation Date: 11 Mar 2022 |
18.43 cr | Open |
|
Others
Creation Date: 27 Oct 2021 |
26.00 cr | Closed |
Business Activity
| Activity Group | Description | Turnover % |
|---|---|---|
| Manufacturing | - | 100.00 |
Flagged By Authority
Regulatory and exchange flags (preview)
Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.
